Kareus Therapeutics
LA CHAUX-DE-FONDS, Switzerland, June 13, 2011 -
- Alliance Combines Innovative Drug Discovery With World-Class
Development Expertise and Global Infrastructure to Expedite Clinical
Proof-of-Relevance in Two Programs
Kareus Therapeutics SA ("Kareus" or the "Company"), the
company focused on the development of novel therapeutics to address high
unmet medical need, today announced a broad strategic alliance with Quintiles
to progress the development of two of Kareus' pre-clinical programs through
clinical trials.
